James C. Mullen is a notable figure in the biotechnology industry, known for his extensive experience in leadership roles. He was the CEO of Biogen, one of the largest biotechnology companies, from 2000 to 2010, guiding the organization during a...

James C. Mullen is a notable figure in the biotechnology industry, known for his extensive experience in leadership roles. He was the CEO of Biogen, one of the largest biotechnology companies, from 2000 to 2010, guiding the organization during a significant period of growth and development. After his time at Biogen, he served as CEO of Patheon until its acquisition by Thermo Fisher in 2017. More recently, Mullen took on the role of President and CEO at Editas Medicine in 2021. He brings a wealth of industry knowledge and expertise, especially in areas like drug development and manufacturing. Mullen holds a degree in Chemical Engineering from Rensselaer Polytechnic Institute and an MBA from Villanova University, showcasing a solid foundation in both technical and business aspects of biotech. Beyond his corporate roles, he also contributes to the industry as a board member and chair for various organizations, helping to shape the future of biotechnology. His journey reflects a commitment to innovation and a deep understanding of the challenges and opportunities within the sector.